These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Clinical and laboratory features, treatment, and outcomes of macrophage activation syndrome in 80 children: a multi-center study in China. Zou LX; Zhu Y; Sun L; Ma HH; Yang SR; Zeng HS; Xiao JH; Yu HG; Guo L; Xu YP; Lu MP World J Pediatr; 2020 Feb; 16(1):89-98. PubMed ID: 31612427 [TBL] [Abstract][Full Text] [Related]
8. Disease Course, Treatments, and Outcomes of Children With Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease. Huang Y; Sompii-Montgomery L; Patti J; Pickering A; Yasin S; Do T; Baker E; Gao D; Abdul-Aziz R; Behrens EM; Canna S; Clark M; Co DO; Collins KP; Eberhard B; Friedman M; Graham TB; Hahn T; Hersh AO; Hobday P; Holland MJ; Huggins J; Lu PY; Mannion ML; Manos CK; Neely J; Onel K; Orandi AB; Ramirez A; Reinhardt A; Riskalla M; Santiago L; Stoll ML; Ting T; Grom AA; Towe C; Schulert GS Arthritis Care Res (Hoboken); 2024 Mar; 76(3):328-339. PubMed ID: 37691306 [TBL] [Abstract][Full Text] [Related]
9. Single center clinical analysis of macrophage activation syndrome complicating juvenile rheumatic diseases. Huang S; Liu Y; Yan W; Zhang T; Wang P; Zhu M; Zhang X; Zhou P; Fan Z; Yu H Pediatr Rheumatol Online J; 2024 May; 22(1):58. PubMed ID: 38783316 [TBL] [Abstract][Full Text] [Related]
10. Pediatric systemic juvenile idiopathic arthritis-related lung disease: Description of clinical cohort and review of management. Swanson C; Khan EK; Cooper A; Ibarra M; Tam-Williams J Pediatr Pulmonol; 2024 Mar; 59(3):724-733. PubMed ID: 38155594 [TBL] [Abstract][Full Text] [Related]
11. Systemic Juvenile Idiopathic Arthritis and Secondary Macrophage Activation Syndrome in Latvia from 2009 to 2020: A Nationwide Retrospective Study. Lukjanoviča K; Šlēziņa I; Dāvidsone Z; Šantere R; Budarina K; Staņēviča V Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109756 [No Abstract] [Full Text] [Related]
12. Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset Still's disease. Ruscitti P; Natoli V; Consolaro A; Caorsi R; Rosina S; Giancane G; Naddei R; Di Cola I; Di Muzio C; Berardicurti O; Iacono D; Pantano I; Rozza G; Rossi S; De Stefano L; Balduzzi S; Vitale A; Caso F; Costa L; Prete M; Navarini L; Iagnocco A; Atzeni F; Guggino G; Perosa F; Cantarini L; Frediani B; Montecucco C; Ciccia F; Cipriani P; Gattorno M; Giacomelli R; Ravelli A Rheumatology (Oxford); 2022 Oct; 61(10):4124-4129. PubMed ID: 35078234 [TBL] [Abstract][Full Text] [Related]
14. Sudden Hypotension and Increased Serum Interferon-γ and Interleukin-10 Predict Early Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis. Guo L; Xu Y; Qian X; Zou L; Zheng R; Teng L; Zheng Q; Leung Jung LK; Lu M J Pediatr; 2021 Aug; 235():203-211.e3. PubMed ID: 33581106 [TBL] [Abstract][Full Text] [Related]
15. Initial Respiratory System Involvement in Juvenile Idiopathic Arthritis with Systemic Onset Is a Marker of Interstitial Lung Disease: The Results of Retrospective Cohort Study Analysis. Belozerov KE; Isupova EA; Solomatina NM; Gaidar EV; Kaneva MA; Chikova IA; Kalashnikova O; Kuznetsova AA; Ivanov DO; Kostik MM J Clin Med; 2024 Jun; 13(13):. PubMed ID: 38999409 [No Abstract] [Full Text] [Related]
16. Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus. Aytaç S; Batu ED; Ünal Ş; Bilginer Y; Çetin M; Tuncer M; Gümrük F; Özen S Rheumatol Int; 2016 Oct; 36(10):1421-9. PubMed ID: 27510530 [TBL] [Abstract][Full Text] [Related]
17. Proceedings from the 2 Canna SW; Schulert GS; de Jesus A; Pickering A; Brunner H; Gadina M; Levine S; Goldbach-Mansky R; Boutelle J; Sinha R; DeBenedetti F; Grom A; Pediatr Rheumatol Online J; 2020 Jul; 18(Suppl 1):53. PubMed ID: 32664935 [TBL] [Abstract][Full Text] [Related]
18. Adenosine deaminase 2 as a biomarker of macrophage activation syndrome in systemic juvenile idiopathic arthritis. Lee PY; Schulert GS; Canna SW; Huang Y; Sundel J; Li Y; Hoyt KJ; Blaustein RB; Wactor A; Do T; Halyabar O; Chang MH; Dedeoglu F; Case SM; Meidan E; Lo MS; Sundel RP; Richardson ET; Newburger JW; Hershfield MS; Son MB; Henderson LA; Nigrovic PA Ann Rheum Dis; 2020 Feb; 79(2):225-231. PubMed ID: 31707357 [TBL] [Abstract][Full Text] [Related]
19. Diagnosis and Management of the Systemic Juvenile Idiopathic Arthritis Patient with Emerging Lung Disease. Towe C; Grom AA; Schulert GS Paediatr Drugs; 2023 Nov; 25(6):649-658. PubMed ID: 37787872 [TBL] [Abstract][Full Text] [Related]
20. The frequency of macrophage activation syndrome and disease course in systemic juvenile idiopathic arthritis. Çakan M; Karadağ ŞG; Tanatar A; Ayaz NA Mod Rheumatol; 2020 Sep; 30(5):900-904. PubMed ID: 31462146 [No Abstract] [Full Text] [Related] [Next] [New Search]